Ingrid Ellerbe

Ingrid is the Executive Director of Diversity by Doing (DxD), a healthtech initiative supported by Stanford Biodesign and Fogarty Innovation.  At DxD her mission is to lead the endeavor of being a transformational force for diversity through an industry-wide initiative formed to raise awareness of inequity, help individuals take action to create a more just and inclusive environment, and provide programs and resources that support systemic change. These efforts span the pipeline from students interested in health technology to start-up and mid-sized healthtech company operations and the myriad of entities that are included in the ecosystem.   She is a former trustee of the NAACP Foundation, and serves on the boards of Stanford Biodesign, Project Tomorrow, Hines Family Foundation, and Better Days Integrated Programs (Bdips). She holds a BA in communications from California State University Dominguez Hills.

Nada Hanafi

Nada joined Veranex (previously Experian Group), in 2017 after working 12 years at FDA’s Center for Devices and Radiological Health (CDRH). Since 2010, she has been a CDRH Senior Science Health Advisor, serving as an expert consultant and senior advisor in the Center Director’s office. Nada combines her deep institutional knowledge with innovative approaches to help companies successfully communicate product information to FDA throughout the total product life cycle. Leveraging her years of reviewer experience and broad FDA exposure, she develops actionable premarket strategies to guide programs through successful submission. She also orchestrates compliance activity. While at FDA, Nada led postmarket investigations for ob-gyn devices, wrinkle fillers, tanning devices, breast implants, negative pressure wound therapy (NPWT) devices and metal-on-metal hip implants and she applies this knowledge to help companies effectively manage postmarket requirements. At Experien Group, Nada helps medical device and combination product manufacturers generate regulatory/clinical roadmaps for success. Building upon her strong engineering background, she helps companies devise and position product performance testing and/or clinical studies to achieve major milestones. Nada holds an MS in Biomaterials and a BE in Biomedical Materials Science & Engineering from Queen Mary College, University of London. She earned her MPH from Johns Hopkins Bloomberg School of Public Health. Nada is a Certified Quality Improvement Associate (CQIA) and a Certified Quality Auditor (CQA) from the American Society for Quality (ASQ).

Sarah Hassaine

Sarah Hassaine is the Head of D&I at ResMed and has been leading the department for nearly 3 years. She has nine years of experience in the D&I space, starting at Amazon where she helped with recruiting and retaining women in Applied Sciences, and then at Qualcomm where she led their conference engagement, affinity group expansion, and their inclusion building programs and initiatives for more than four years. Prior, Sarah worked in international development and government consulting with Deloitte around the world. She worked at InterNews supporting democracy development in the MENA region, and in Riyadh, Saudi Arabia, leading an organization for up-skilling and training ex-pat women. Sarah is very devoted to community empowerment and has done work in cross-cultural and intra-faith initiatives. At home in San Diego, she devotes her time to refugee assimilation efforts, as well as across the border in Mexico with orphanages through the Alma Foundation. Sarah currently serves on three Boards - the Southwest chapter of Planned Parenthood, the Kim Center for Social Balance championing workforce equity, and the North San Diego Business Chamber. Sarah earned her Executive MBA from the Wharton Business School at UPenn in 2021, her MA in Policy from George Washington University, and her BA in International Affairs from UC San Diego.

Tiffany Summerville

Tiffany Summerville is the VP of Human Resources at Sherlock Biosciences. A seasoned human resources strategist with more than 20 years of experience in the pharmaceutical industry, Tiffany is committed to marrying a business strategy with employee development.  Tiffany understands how human resources impacts an organization’s bottom line and has a track-record of building high-performance organizations with exceptional cultures.

Most recently, Tiffany served as the Director of Human Resources at  Acorda Therapeutics, Inc., where she was responsible for all aspects of HR including employee relations, learning and development, benefits, performance management, leadership development strategy, and diversity and inclusion program development. Prior to Acorda Therapeutics, Tiffany led talent acquisition efforts at Barr Pharmaceuticals and Alternative Resources Company, where she developed broad expertise in all aspects of the recruitment life-cycle from candidate sourcing and onboarding through retention strategies and leadership development.

Tiffany obtained her Bachelor of Science in Communications with a minor in Marketing from one of the oldest Historically Black Colleges and Universities (HBCU), Bowie State University, and is a proud member of Alpha Kappa Alpha Sorority, Incorporated. She also serves as the President of the professional association, Women of Color in Corporate America. Tiffany holds numerous human resource certifications and accreditations, as well as memberships in the Society for Human Resource Management and the American Society for Training and Development.

Kwame Ulmer

Kwame Ulmer is the Managing Partner at MedTech Impact Partners - A Regulatory Strategy Consulting Firm. Kwame brings over two decades of experience evaluating medical technologies in the government and private sector, and serving in senior operating roles at medical device companies to help companies successfully engage the FDA. He has personally evaluated more than 1,000 medical technologies in his career. Kwame spent 12 years at the FDA in progressive leadership roles. He also served as Vice President, Regulatory Affairs and Quality Assurance at Implant Direct, a Danaher Corporation operating company.

He is also a venture partner at Wavemaker Three-Sixty Health – the leading Southern-California based, early stage venture capital firm (Seed and Series A) focused on the healthcare industry. He leads the medtech practice and participates in all aspects of fund management (e.g. deal sourcing, diligence, negotiation and advising portfolio company management teams). Kwame sits on the board and advises several privately held medtech companies.

Kwame serves on the boards of Essenvia Inc and Strados Labs. Kwame is a board member  of the Lincoln University Foundation, University of Virginia Licensing and Ventures Group and California Life Sciences. He is also a lecturer and researcher in medtech innovation at the University of California, Los Angeles. Kwame founded MedTech Color, a nonprofit with a mission to advance the representation of persons of color in the medical device industry. He earned his B.S. in Physics from Lincoln University, and has two Masters degrees from the University of Virginia, in Materials Engineering and Business Administration.